Trial Profile
An Open, Randomised, Two-period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of GW273225 Administered Immediately After Food and Administered in Fasted State to Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GW 273225 (Primary)
- Indications Affective disorders; Cognition disorders; Epilepsy
- Focus Pharmacokinetics
- Sponsors GSK
- 13 Nov 2007 Status changed frm initiated to completed from NCT
- 13 Aug 2007 New trial record.